Wallingford, CT, United States of America

Richard Pracitto

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 5.2

ph-index = 3

Forward Citations = 32(Granted Patents)


Company Filing History:


Years Active: 2012-2013

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Richard Pracitto: Innovator in Hepatitis C Treatment

Introduction

Richard Pracitto is a notable inventor based in Wallingford, CT (US). He has made significant contributions to the field of medicine, particularly in the treatment of hepatitis C. With a total of 4 patents to his name, Pracitto's work has the potential to impact many lives.

Latest Patents

Pracitto's latest patents focus on compounds for the treatment of hepatitis C. The disclosures provide compounds of formula I, II, III, IV, and V, including their salts, as well as compositions and methods of using these compounds. These compounds exhibit activity against the hepatitis C virus (HCV) and may be useful in treating those infected with HCV. Additionally, another patent details compounds of formula I, including their salts, along with compositions and methods for their use, further emphasizing their potential in combating HCV.

Career Highlights

Richard Pracitto is currently employed at Bristol-Myers Squibb Company, a leading biopharmaceutical company. His work there has allowed him to focus on innovative solutions for serious health issues, particularly in viral infections.

Collaborations

Some of his notable coworkers include John F Kadow and John A Bender. Their collaboration in research and development has contributed to the advancement of treatments in their field.

Conclusion

Richard Pracitto's contributions to the treatment of hepatitis C through his innovative patents highlight his dedication to improving healthcare. His work at Bristol-Myers Squibb Company and collaborations with esteemed colleagues further underscore his impact in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…